As Western governments reduce foreign aid, that imbalance is becoming increasingly difficult to ignore. The question is no longer simply how Africa will replace lost funding, but how the current situation will redefine health as an issue of sovereignty and foreign policy. At stake is a broader renegotiation of who sets Africa’s health priorities, who finances them, and how international partnerships support them. For more than three decades, external donors financed vaccination campaigns, disease surveillance, HIV treatment, maternal health programmes, and emergency outbreak responses across the continent. This support saved millions of lives, yet it also created long-term dependence on external financing, imported medical products, and donor-driven priorities. It is imperative that Africa reconsider its approach to health funding by building domestic resilience to protect its health sovereignty. A Global Health Financing Model Under Strain The current funding crisis ...
Middle powers like Canada, Germany, and Brazil are caught in an escalating geopolitical vice. As protectionist sentiment in Washington creates new trade barriers, middle powers face growing pressure to seek alternative markets. However, reflexively pivoting toward Beijing carries significant strategic risks. China currently holds a near-monopoly on critical mineral processing, controlling over 90 percent of global battery-grade graphite and rare earth elements. Trading economic reliance on the United States for strategic dependence on China does not deliver autonomy; it merely exchanges one vulnerability for another. The true, sustainable off-ramp for middle powers lies across the Atlantic by deepening strategic trade partnerships with African economies. Long relegated to the periphery of Western foreign policy or viewed through the outdated lens of foreign aid, the African continent is undergoing a massive structural transformation. Driven by the African Continental Free Trade ...